Category Archives: Avandia

Featured Stories

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Avandia Mediation Nets Settlement for 20,000 Heart Attack Lawsuits

Pharmaceutical giant GlaxoSmithKline has agreed to settle about 20,000 heart attack lawsuits brought by former users of its Type 2 diabetes medication Avandia. The lawsuits are among thousands more which claim GlaxoSmithKline (GSK) hid data showing the leading diabetes drug … Continue reading

Posted in Avandia, Pharmaceuticals |

Glaxo May Mediate More Avandia Settlements

Last week, we wrote that GlaxoSmithKline Plc agreed to pay $3 billion to resolve federal investigations into how it marketed some of its drugs, including its controversial type 2 diabetes drug, Avandia. Now, a judge is urging the drug maker … Continue reading

Posted in Avandia, Pharmaceuticals |

Glaxo to Settle Avandia, Other Federal Drug Marketing Investigations

GlaxoSmithKline has agreed to pay $3 billion to resolve federal investigations into the marketing of some of its drugs, including the controversial type 2 diabetes drug, < "http://www.yourlawyer.com/topics/overview/avandia">Avandia. According to a report from Bloomberg News, the agreement with the U.S. … Continue reading

Posted in Avandia, Pharmaceuticals |

More Avandia Lawsuits Filed In Illinois

More < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuits have been filed, this time, in Illinois. Most recently, we wrote that eight plaintiffs filed a lawsuit in Texas against GlaxoSmithKline, maker of the once-popular diabetes medication. The two Illinois plaintiffs allege that GlaxoSmithKline should not … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Lawsuit Filed by 8 in Texas

A group of Texas plaintiffs have added to the pile of < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuits heading to court. The 8 individuals filed suit against GlaxoSmithKline alleging Avandia caused them to suffer various heart problems, and are seeking a full refund for … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Lawsuit Filed By 90+ Plaintiffs

A large group of over 90 people who took diabetes drug, < "http://www.yourlawyer.com/topics/overview/avandia">Avandia, have filed a lawsuit against the maker of the controversial medication, GlaxoSmithKline. The 14-count lawsuit seeks over $700,000, including costs, legal fees, and other relief. The Madison … Continue reading

Posted in Avandia, Pharmaceuticals |

Actos, Avandia Linked to Higher Incidence of Eye Disorder

< "http://www.yourlawyer.com/topics/overview/actos">Actos and < "http://www.yourlawyer.com/topics/overview/avandia">Avandia increase the risk that users will develop diabetic macular edema, a serious eye disorder that can lead to blindness. According to a study presented at the American Diabetes Association’s annual meeting in San Diego, people … Continue reading

Posted in Actos, Avandia, Pharmaceuticals |

Chantix Side Effects Not Reported Properly, FDA Says

The U.S. Food and Drug Administration (FDA) just announced that it asked drug maker, Pfizer Inc., to submit—again—a large amount of its adverse event reports from 2010 for < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix, its stop smoking medication, said the Wall Street Journal. On … Continue reading

Posted in Avandia, Pharmaceuticals |

GlaxoSmithKline Close to Settling More Avandia Lawsuits

It looks like GlaxoSmithKline may be preparing to settle more < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuits. According to a report from Bloomberg News, the Avandia settlements would cover roughly 1,000 former Avandia users who sued the company in state courts in Pennsylvania, California … Continue reading

Posted in Avandia, Pharmaceuticals |

Avandia Named in Texas Wrongful Death Suit

GlaxoSmithKline is facing yet another < "http://www.yourlawyer.com/topics/overview/avandia">Avandia lawsuit, this time for the alleged wrongful death of a Texas man. The Avandia lawsuit claims the fatal heart attacked suffered by James Michael Knight in 2009 was the result of his taking … Continue reading

Posted in Avandia, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.